It was further demonstrated that GSK-3β inhibition or down-regulation leads to a decrease in NF-κB activity within glioma cell lines [127] and that GSK-3β has a role in modulating cell proliferation in prostate and colon cancer [128,129]. The gene discussed is NFKB1; the disease is malignant colon neoplasm.